Arrowstreet Capital Limited Partnership Acquires 263,034 Shares of AngioDynamics, Inc. (NASDAQ:ANGO)

Arrowstreet Capital Limited Partnership boosted its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 293.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 352,544 shares of the medical instruments supplier's stock after purchasing an additional 263,034 shares during the quarter. Arrowstreet Capital Limited Partnership owned about 0.87% of AngioDynamics worth $3,229,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ANGO. SBI Securities Co. Ltd. acquired a new stake in shares of AngioDynamics in the 4th quarter valued at about $28,000. R Squared Ltd bought a new position in AngioDynamics in the fourth quarter worth approximately $49,000. US Bancorp DE grew its stake in AngioDynamics by 1,938.0% in the fourth quarter. US Bancorp DE now owns 6,705 shares of the medical instruments supplier's stock valued at $61,000 after acquiring an additional 6,376 shares during the period. SG Americas Securities LLC increased its holdings in shares of AngioDynamics by 21.3% during the fourth quarter. SG Americas Securities LLC now owns 16,102 shares of the medical instruments supplier's stock valued at $147,000 after acquiring an additional 2,832 shares in the last quarter. Finally, Intech Investment Management LLC bought a new position in shares of AngioDynamics in the 4th quarter worth $152,000. 89.43% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, SVP Warren Nighan, Jr. sold 4,060 shares of AngioDynamics stock in a transaction that occurred on Thursday, January 16th. The shares were sold at an average price of $12.31, for a total value of $49,978.60. Following the sale, the senior vice president now owns 41,817 shares of the company's stock, valued at approximately $514,767.27. The trade was a 8.85 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 5.40% of the company's stock.

AngioDynamics Stock Up 2.5 %

NASDAQ:ANGO traded up $0.23 during trading hours on Monday, hitting $9.52. 52,603 shares of the company traded hands, compared to its average volume of 712,370. AngioDynamics, Inc. has a one year low of $5.47 and a one year high of $13.50. The company has a market cap of $386.58 million, a PE ratio of -1.69 and a beta of 0.52. The firm's 50-day simple moving average is $9.80 and its 200-day simple moving average is $8.96.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last posted its quarterly earnings data on Wednesday, April 2nd. The medical instruments supplier reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.13) by $0.16. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. The firm had revenue of $72.00 million during the quarter, compared to analyst estimates of $70.30 million. The business's revenue for the quarter was down 4.3% on a year-over-year basis. As a group, equities research analysts expect that AngioDynamics, Inc. will post -0.37 EPS for the current year.

Analyst Ratings Changes

Separately, HC Wainwright restated a "buy" rating and set a $16.00 price objective (up previously from $15.00) on shares of AngioDynamics in a report on Monday, April 7th.

AngioDynamics Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.